Physician profile
Dixie Rasmussen
NPI 1740385046
$577.34
in general payments reported to CMS, 2019-2025
15 companies · $50.82 in 2025
The $50.82 reported for 2025 was less than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $215 · 2023: $36.94 · 2024: $51.75 · 2025: $50.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $142.99 | 2021-2025 | |
| Lilly USA, LLC | $80.47 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $50.69 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.20 | 2022 | |
| Zimmer Biomet Holdings, INC. | $39.03 | 2022 | |
| Merck Sharp & Dohme LLC | $33.48 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $29.02 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.82 | 2021 | |
| Pfizer INC. | $25.36 | 2021-2022 | |
| Novo Nordisk INC | $24.96 | 2021 | |
| Baxter Healthcare | $23.15 | 2023 | Hillrom - Life 2000 Ventilation System |
| Sanofi-Aventis U.S. LLC | $16.53 | 2021 | |
| Idorsia Pharmaceuticals US INC | $14.15 | 2024 | Quviviq |
| Organon LLC | $13.87 | 2025 | Nexplanon |
| Eisai INC. | $12.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dixie Rasmussen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.